<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39338480</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-2607</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>31</Day></PubDate></JournalIssue><Title>Microorganisms</Title><ISOAbbreviation>Microorganisms</ISOAbbreviation></Journal><ArticleTitle>Clinical Manifestations, Macrolide Resistance, and Treatment Utilization Trends of <i>Mycoplasma pneumoniae</i> Pneumonia in Children and Adolescents in South Korea.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1806</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/microorganisms12091806</ELocationID><Abstract><AbstractText>A resurgence of <i>Mycoplasma pneumoniae</i> (MP)-the leading cause of community-acquired bacterial pneumonia, particularly in children-occurred following the COVID-19 pandemic. We aimed to investigate the clinical manifestations, macrolide resistance patterns, and therapeutic approaches related to the MP pneumonia epidemic. Children and adolescents diagnosed with MP pneumonia in September-December 2023 were screened. Clinical data were retrospectively collected from 13 major hospitals using concordant microbiological criteria, including either a positive PCR result or four-fold increase in serological markers. Demographic characteristics, treatment modalities, and clinical outcomes were analyzed. Of the 474 screened patients, 374 (median age: 7.7 [IQR, 5.4-9.6] years; hospitalization rate: 88.6%) met the microbiological confirmation criteria. Most patients experienced fever (98.9%), and lobular/lobar consolidation (59.1%) was the dominant radiological finding. The macrolide resistance rate remained high at 87.0%; corticosteroids were widely used (55.6%) alongside macrolides, despite resistance. Patients with consolidation had prolonged fever (median 8 vs. 7 days, <i>p</i> = 0.020) and higher hospitalization rates (92.3% vs. 83.0%, <i>p</i> = 0.008). Macrolide resistance did not significantly influence radiological outcomes. This study highlights the ongoing challenge of macrolide resistance in MP pneumonia and need for tailored therapeutic approaches. Despite high resistance, macrolides remain commonly prescribed, often concurrently with corticosteroids.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Joon Kee</ForeName><Initials>JK</Initials><Identifier Source="ORCID">0000-0001-8191-0812</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju 28644, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Taekjin</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-8912-6982</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, CHA Bundang Medical Center, CHA University, Seongnam 13496, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Yae-Jean</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Samsung Medical Center, School of Medicine, Sungkyungwan University, Seoul 06351, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Doo Ri</ForeName><Initials>DR</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Samsung Medical Center, School of Medicine, Sungkyungwan University, Seoul 06351, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shin</LastName><ForeName>Areum</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Samsung Medical Center, School of Medicine, Sungkyungwan University, Seoul 06351, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Hyun Mi</ForeName><Initials>HM</Initials><Identifier Source="ORCID">0000-0003-0513-8407</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Ye Ji</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Dong Hyun</ForeName><Initials>DH</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Inha University College of Medicine, Incheon 22212, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eun</LastName><ForeName>Byung Wook</ForeName><Initials>BW</Initials><Identifier Source="ORCID">0000-0003-3147-9061</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, Eulji University Eulji General Hospital, Seoul 01830, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choe</LastName><ForeName>Young June</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Korea University Anam Hospital, and Allergy and Immunology Center, Korea University, Seoul 02841, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Hyunju</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-0107-0724</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, Seoul National University Bundang Hospital, Seongnam 13620, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Young Min</ForeName><Initials>YM</Initials><Identifier Source="ORCID">0000-0002-0987-4180</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, Seoul National University Bundang Hospital, Seongnam 13620, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Eun Young</ForeName><Initials>EY</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Chungnam National University Hospital, Daejeon 35015, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Kyung Min</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Chungnam National University Hospital, Daejeon 35015, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwak</LastName><ForeName>Byung Ok</ForeName><Initials>BO</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Hallym University Kangnam Sacred Heart Hospital, Seoul 07441, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Su Eun</ForeName><Initials>SE</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan 50612, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jo</LastName><ForeName>Kyo Jin</ForeName><Initials>KJ</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan 50612, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Jae Hong</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Jeju National University School of Medicine, Jeju 63243, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Dayun</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Seoul National University Children's Hospital, Seoul 03080, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Eun Hwa</ForeName><Initials>EH</Initials><Identifier Source="ORCID">0000-0002-5857-0749</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Seoul National University Children's Hospital, Seoul 03080, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yun</LastName><ForeName>Ki Wook</ForeName><Initials>KW</Initials><Identifier Source="ORCID">0000-0002-0798-6779</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Seoul National University Children's Hospital, Seoul 03080, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2023090EDDA</GrantID><Agency>Korea Disease Control and Prevention Agency</Agency><Country /></Grant><Grant><GrantID>N/A</GrantID><Agency>Korean Society of Pediatric Infectious Diseases</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Microorganisms</MedlineTA><NlmUniqueID>101625893</NlmUniqueID><ISSNLinking>2076-2607</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">adolescent</Keyword><Keyword MajorTopicYN="N">child</Keyword><Keyword MajorTopicYN="N">macrolides</Keyword><Keyword MajorTopicYN="N">mycoplasma pneumoniae</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39338480</ArticleId><ArticleId IdType="pmc">PMC11434231</ArticleId><ArticleId IdType="doi">10.3390/microorganisms12091806</ArticleId><ArticleId IdType="pii">microorganisms12091806</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Jain S., Williams D.J., Arnold S.R., Ampofo K., Bramley A.M., Reed C., Stockmann C., Anderson E.J., Grijalva C.G., Self W.H., et al. Community-acquired pneumonia requiring hospitalization among U.S. children. N. Engl. J. Med. 2015;372:835–845. doi: 10.1056/NEJMoa1405870.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1405870</ArticleId><ArticleId IdType="pmc">PMC4697461</ArticleId><ArticleId IdType="pubmed">25714161</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer Sauteur P.M., Unger W.W.J., van Rossum A.M.C., Berger C. The Art and Science of Diagnosing Mycoplasma pneumoniae Infection. Pediatr. Infect. Dis. J. 2018;37:1192–1195. doi: 10.1097/INF.0000000000002171.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000002171</ArticleId><ArticleId IdType="pubmed">30169485</ArticleId></ArticleIdList></Reference><Reference><Citation>Waites K.B., Xiao L., Liu Y., Balish M.F., Atkinson T.P. Mycoplasma pneumoniae from the Respiratory Tract and Beyond. Clin. Microbiol. Rev. 2017;30:747–809. doi: 10.1128/CMR.00114-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00114-16</ArticleId><ArticleId IdType="pmc">PMC5475226</ArticleId><ArticleId IdType="pubmed">28539503</ArticleId></ArticleIdList></Reference><Reference><Citation>Okazaki N., Narita M., Yamada S., Izumikawa K., Umetsu M., Kenri T., Sasaki Y., Arakawa Y., Sasaki T. Characteristics of macrolide-resistant Mycoplasma pneumoniae strains isolated from patients and induced with erythromycin in vitro. Microbiol. Immunol. 2001;45:617–620. doi: 10.1111/j.1348-0421.2001.tb01293.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1348-0421.2001.tb01293.x</ArticleId><ArticleId IdType="pubmed">11592636</ArticleId></ArticleIdList></Reference><Reference><Citation>Okada T., Morozumi M., Tajima T., Hasegawa M., Sakata H., Ohnari S., Chiba N., Iwata S., Ubukata K. Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children. Clin. Infect. Dis. 2012;55:1642–1649. doi: 10.1093/cid/cis784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/cis784</ArticleId><ArticleId IdType="pubmed">22972867</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawai Y., Miyashita N., Kubo M., Akaike H., Kato A., Nishizawa Y., Saito A., Kondo E., Teranishi H., Wakabayashi T., et al. Nationwide surveillance of macrolide-resistant Mycoplasma pneumoniae infection in pediatric patients. Antimicrob. Agents Chemother. 2013;57:4046–4049. doi: 10.1128/AAC.00663-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.00663-13</ArticleId><ArticleId IdType="pmc">PMC3719750</ArticleId><ArticleId IdType="pubmed">23716043</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim K., Jung S., Kim M., Park S., Yang H.J., Lee E. Global Trends in the Proportion of Macrolide-Resistant Mycoplasma pneumoniae Infections: A Systematic Review and Meta-analysis. JAMA Netw. Open. 2022;5:e2220949. doi: 10.1001/jamanetworkopen.2022.20949.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.20949</ArticleId><ArticleId IdType="pmc">PMC9274321</ArticleId><ArticleId IdType="pubmed">35816304</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J.K., Lee J.H., Lee H., Ahn Y.M., Eun B.W., Cho E.Y., Cho H.J., Yun K.W., Lee H.J., Choi E.H. Clonal Expansion of Macrolide-Resistant Sequence Type 3 Mycoplasma pneumoniae, South Korea. Emerg. Infect. Dis. 2018;24:1465–1471. doi: 10.3201/eid2408.180081.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2408.180081</ArticleId><ArticleId IdType="pmc">PMC6056092</ArticleId><ArticleId IdType="pubmed">30014844</ArticleId></ArticleIdList></Reference><Reference><Citation>Waites K.B., Ratliff A., Crabb D.M., Xiao L., Qin X., Selvarangan R., Tang Y.W., Zheng X., Dien Bard J., Hong T., et al. Macrolide-Resistant Mycoplasma pneumoniae in the United States as Determined from a National Surveillance Program. J. Clin. Microbiol. 2019;57:e00968-19. doi: 10.1128/JCM.00968-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00968-19</ArticleId><ArticleId IdType="pmc">PMC6813023</ArticleId><ArticleId IdType="pubmed">31484701</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan C., Xue G.H., Zhao H.Q., Feng Y.L., Cui J.H., Yuan J. Current status of Mycoplasma pneumoniae infection in China. World J. Pediatr. 2024;20:1–4. doi: 10.1007/s12519-023-00783-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12519-023-00783-x</ArticleId><ArticleId IdType="pmc">PMC10827902</ArticleId><ArticleId IdType="pubmed">38185707</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie X.Y., Zhou R.Y., Ding S.A., Ma B.X., Zhang X., Zhang Y. Emerging trends and concerns in Mycoplasma pneumoniae pneumonia among Chinese pediatric population. Pediatr. Res. 2024;95:1388–1390. doi: 10.1038/s41390-024-03049-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41390-024-03049-y</ArticleId><ArticleId IdType="pubmed">38273116</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Wu M., Liang Y., Yang Y., Guo W., Deng Y., Wen T., Tan C., Lin C., Liu F., et al. Mycoplasma pneumoniae infection outbreak in Guangzhou, China after COVID-19 pandemic. Virol. J. 2024;21:183. doi: 10.1186/s12985-024-02458-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-024-02458-z</ArticleId><ArticleId IdType="pmc">PMC11318190</ArticleId><ArticleId IdType="pubmed">39129001</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J.H., Roh Y.H., Ahn J.G., Kim M.Y., Huh K., Jung J., Kang J.M. Respiratory syncytial virus and influenza epidemics disappearance in Korea during the 2020-2021 season of COVID-19. Int. J. Infect. Dis. 2021;110:29–35. doi: 10.1016/j.ijid.2021.07.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.07.005</ArticleId><ArticleId IdType="pubmed">34245886</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang M., Zhang H., Yao F., Lu Q., Sun Q., Liu Z., Li Q., Wu G. Influence of non-pharmaceutical interventions on epidemiological characteristics of Mycoplasma pneumoniae infection in children during and after the COVID-19 epidemic in Ningbo, China. Front. Microbiol. 2024;15:1405710. doi: 10.3389/fmicb.2024.1405710.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2024.1405710</ArticleId><ArticleId IdType="pmc">PMC11288959</ArticleId><ArticleId IdType="pubmed">39086655</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J.K., Choi Y.Y., Sohn Y.J., Kim K.M., Kim Y.K., Han M.S., Park J.Y., Cho E.Y., Choi J.H., Choi E.H. Persistent high macrolide resistance rate and increase of macrolide-resistant ST14 strains among Mycoplasma pneumoniae in South Korea, 2019–2020. J. Microbiol. Immunol. Infect. 2022;55:910–916. doi: 10.1016/j.jmii.2021.07.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2021.07.011</ArticleId><ArticleId IdType="pubmed">34475003</ArticleId></ArticleIdList></Reference><Reference><Citation>Korea Disease Control and Prevention Agency  Acute Respiratory Infection Network (ARI Net)  [(accessed on 15 April 2024)]; Available online:  https://www.kdca.go.kr/contents.es?mid=a20301090502.</Citation></Reference><Reference><Citation>Korea Disease Control and Prevention Agency  Doubling of Mycoplasma pneumoniae Infections in the Last 4 Weeks.  [(accessed on 30 June 2024)]; Available online:  https://www.kdca.go.kr/board/board.es?mid=a20501020000&amp;bid=0015&amp;list_no=723863&amp;cg_code=C01&amp;act=view&amp;nPage=1&amp;newsField=</Citation></Reference><Reference><Citation>Waites K.B., Xiao L., Paralanov V., Viscardi R.M., Glass J.I. Molecular methods for the detection of Mycoplasma and ureaplasma infections in humans: A paper from the 2011 William Beaumont Hospital Symposium on molecular pathology. J. Mol. Diagn. 2012;14:437–450. doi: 10.1016/j.jmoldx.2012.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmoldx.2012.06.001</ArticleId><ArticleId IdType="pmc">PMC3427874</ArticleId><ArticleId IdType="pubmed">22819362</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong K.B., Choi E.H., Lee H.J., Lee S.Y., Cho E.Y., Choi J.H., Kang H.M., Lee J., Ahn Y.M., Kang Y.H., et al. Macrolide resistance of Mycoplasma pneumoniae, South Korea, 2000–2011. Emerg. Infect. Dis. 2013;19:1281–1284. doi: 10.3201/eid1908.121455.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1908.121455</ArticleId><ArticleId IdType="pmc">PMC3739509</ArticleId><ArticleId IdType="pubmed">23876792</ArticleId></ArticleIdList></Reference><Reference><Citation>Fine M.J., Auble T.E., Yealy D.M., Hanusa B.H., Weissfeld L.A., Singer D.E., Coley C.M., Marrie T.J., Kapoor W.N. A prediction rule to identify low-risk patients with community-acquired pneumonia. N. Engl. J. Med. 1997;336:243–250. doi: 10.1056/NEJM199701233360402.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199701233360402</ArticleId><ArticleId IdType="pubmed">8995086</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanata M.M., Wang H., Everhart K., Moore-Clingenpeel M., Ramilo O., Leber A. Macrolide-Resistant Mycoplasma pneumoniae Infections in Children, Ohio, USA. Emerg. Infect. Dis. 2021;27:1588–1597. doi: 10.3201/eid2706.203206.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2706.203206</ArticleId><ArticleId IdType="pmc">PMC8153876</ArticleId><ArticleId IdType="pubmed">34013867</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka T., Oishi T., Miyata I., Wakabayashi S., Kono M., Ono S., Kato A., Fukuda Y., Saito A., Kondo E., et al. Macrolide-Resistant Mycoplasma pneumoniae Infection, Japan, 2008–2015. Emerg. Infect. Dis. 2017;23:1703–1706. doi: 10.3201/eid2310.170106.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2310.170106</ArticleId><ArticleId IdType="pmc">PMC5621555</ArticleId><ArticleId IdType="pubmed">28930026</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S.H., Jung S.O., Yoo J., Hwang K.J. Prevalence and frequency of macrolide-resistant in Mycoplasma pneumoniae in children with acute respiratory infections in Korea, 2018–2019. Public Health Wkly. Rep. 2019;12:1969–1971.</Citation></Reference><Reference><Citation>Wu T.H., Fang Y.P., Liu F.C., Pan H.H., Yang Y.Y., Song C.S., Lee C.Y. Macrolide-Resistant Mycoplasma pneumoniae Infections among Children before and during COVID-19 Pandemic, Taiwan, 2017–2023. Emerg. Infect. Dis. 2024;30:1692–1696. doi: 10.3201/eid3008.231596.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid3008.231596</ArticleId><ArticleId IdType="pmc">PMC11286047</ArticleId><ArticleId IdType="pubmed">39043456</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucier T.S., Heitzman K., Liu S.K., Hu P.C. Transition mutations in the 23S rRNA of erythromycin-resistant isolates of Mycoplasma pneumoniae. Antimicrob. Agents Chemother. 1995;39:2770–2773. doi: 10.1128/AAC.39.12.2770.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.39.12.2770</ArticleId><ArticleId IdType="pmc">PMC163027</ArticleId><ArticleId IdType="pubmed">8593017</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y.J., Shin K.S., Lee K.H., Kim Y.R., Choi J.H. Clinical Characteristics of Macrolide-Resistant Mycoplasma pneumoniae from Children in Jeju. J. Korean Med. Sci. 2017;32:1642–1646. doi: 10.3346/jkms.2017.32.10.1642.</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2017.32.10.1642</ArticleId><ArticleId IdType="pmc">PMC5592178</ArticleId><ArticleId IdType="pubmed">28875608</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing F.F., Chiu K.H., Deng C.W., Ye H.Y., Sun L.L., Su Y.X., Cai H.J., Lo S.K., Rong L., Chen J.L., et al. Post-COVID-19 Pandemic Rebound of Macrolide-Resistant Mycoplasma pneumoniae Infection: A Descriptive Study. Antibiotics. 2024;13:262. doi: 10.3390/antibiotics13030262.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antibiotics13030262</ArticleId><ArticleId IdType="pmc">PMC10967482</ArticleId><ArticleId IdType="pubmed">38534697</ArticleId></ArticleIdList></Reference><Reference><Citation>Gardiner S.J., Gavranich J.B., Chang A.B. Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children. Cochrane Database Syst. Rev. 2015;1:CD004875. doi: 10.1002/14651858.CD004875.pub5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD004875.pub5</ArticleId><ArticleId IdType="pmc">PMC10585423</ArticleId><ArticleId IdType="pubmed">25566754</ArticleId></ArticleIdList></Reference><Reference><Citation>Biondi E., McCulloh R., Alverson B., Klein A., Dixon A., Ralston S. Treatment of mycoplasma pneumonia: A systematic review. Pediatrics. 2014;133:1081–1090. doi: 10.1542/peds.2013-3729.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2013-3729</ArticleId><ArticleId IdType="pubmed">24864174</ArticleId></ArticleIdList></Reference><Reference><Citation>American Academy of Pediatrics . Tables of antibacterial drug dosages. In: Kimberlin D.W.B.E., Lynfield R., Sawyer M.H., editors. Red Book: 2021–2024 Report of the Committee on Infectious Diseases. 32nd ed. American Academy of Pediatrics; Itasca, IL, USA: 2021. p. 876.</Citation></Reference><Reference><Citation>McCreary E.K., Johnson M.D., Jones T.M., Spires S.S., Davis A.E., Dyer A.P., Ashley E.D., Gallagher J.C. Antibiotic Myths for the Infectious Diseases Clinician. Clin. Infect. Dis. 2023;77:1120–1125. doi: 10.1093/cid/ciad357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciad357</ArticleId><ArticleId IdType="pubmed">37310038</ArticleId></ArticleIdList></Reference><Reference><Citation>Song S.H., Lee H., Lee H.J., Song E.S., Ahn J.G., Park S.E., Lee T., Cho H.K., Lee J., Kim Y.J., et al. Twenty-Five Year Trend Change in the Etiology of Pediatric Invasive Bacterial Infections in Korea, 1996–2020. J. Korean Med. Sci. 2023;38:e127. doi: 10.3346/jkms.2023.38.e127.</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2023.38.e127</ArticleId><ArticleId IdType="pmc">PMC10125790</ArticleId><ArticleId IdType="pubmed">37096310</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarogoulidis P., Papanas N., Kioumis I., Chatzaki E., Maltezos E., Zarogoulidis K. Macrolides: From in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases. Eur. J. Clin. Pharmacol. 2012;68:479–503. doi: 10.1007/s00228-011-1161-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00228-011-1161-x</ArticleId><ArticleId IdType="pubmed">22105373</ArticleId></ArticleIdList></Reference><Reference><Citation>Okumura T., Kawada J.I., Tanaka M., Narita K., Ishiguro T., Hirayama Y., Narahara S., Tsuji G., Sugiyama Y., Suzuki M., et al. Comparison of high-dose and low-dose corticosteroid therapy for refractory Mycoplasma pneumoniae pneumonia in children. J. Infect. Chemother. 2019;25:346–350. doi: 10.1016/j.jiac.2019.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiac.2019.01.003</ArticleId><ArticleId IdType="pubmed">30718192</ArticleId></ArticleIdList></Reference><Reference><Citation>He M., Xie J., Rui P., Li X., Lai M., Xue H., Chen C. Clinical efficacy of macrolide antibiotics in Mycoplasma pneumoniae pneumonia carrying a macrolide-resistant mutation in the 23 S rRNA gene in pediatric patients. BMC Infect. Dis. 2024;24:758. doi: 10.1186/s12879-024-09612-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-024-09612-6</ArticleId><ArticleId IdType="pmc">PMC11292884</ArticleId><ArticleId IdType="pubmed">39085799</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Zhang Y., Sheng Y., Zhang L., Shen Z., Chen Z. More complications occur in macrolide-resistant than in macrolide-sensitive Mycoplasma pneumoniae pneumonia. Antimicrob. Agents Chemother. 2014;58:1034–1038. doi: 10.1128/AAC.01806-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.01806-13</ArticleId><ArticleId IdType="pmc">PMC3910883</ArticleId><ArticleId IdType="pubmed">24277047</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon I.A., Hong K.B., Lee H.J., Yun K.W., Park J.Y., Choi Y.H., Kim W.S., Lee H., Eun B.W., Ahn Y.M., et al. Radiologic findings as a determinant and no effect of macrolide resistance on clinical course of Mycoplasma pneumoniae pneumonia. BMC Infect. Dis. 2017;17:402. doi: 10.1186/s12879-017-2500-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-017-2500-z</ArticleId><ArticleId IdType="pmc">PMC5463359</ArticleId><ArticleId IdType="pubmed">28592263</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun L.L., Ye C., Zhou Y.L., Zuo S.R., Deng Z.Z., Wang C.J. Meta-analysis of the Clinical Efficacy and Safety of High- and Low-dose Methylprednisolone in the Treatment of Children With Severe Mycoplasma pneumoniae Pneumonia. Pediatr. Infect. Dis. J. 2020;39:177–183. doi: 10.1097/INF.0000000000002529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000002529</ArticleId><ArticleId IdType="pubmed">31738328</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>